NCT02995720View on ClinicalTrials.gov

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 26, 2016

Primary Completion Date

November 10, 2016

Study Completion Date

May 30, 2017

Conditions
Hypertension, Hyperlipidemia
Interventions
DRUG

Fimasartan/Amlodipine combination drug, Rosuvastatin

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY